標(biāo)題: Titlebook: Genomics and Proteomics for Clinical Discovery and Development; Gy?rgy Marko-Varga Book 2014 Springer Science+Business Media Dordrecht 201 [打印本頁(yè)] 作者: 候選人名單 時(shí)間: 2025-3-21 16:19
書目名稱Genomics and Proteomics for Clinical Discovery and Development影響因子(影響力)
書目名稱Genomics and Proteomics for Clinical Discovery and Development影響因子(影響力)學(xué)科排名
書目名稱Genomics and Proteomics for Clinical Discovery and Development網(wǎng)絡(luò)公開度
書目名稱Genomics and Proteomics for Clinical Discovery and Development網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Genomics and Proteomics for Clinical Discovery and Development被引頻次
書目名稱Genomics and Proteomics for Clinical Discovery and Development被引頻次學(xué)科排名
書目名稱Genomics and Proteomics for Clinical Discovery and Development年度引用
書目名稱Genomics and Proteomics for Clinical Discovery and Development年度引用學(xué)科排名
書目名稱Genomics and Proteomics for Clinical Discovery and Development讀者反饋
書目名稱Genomics and Proteomics for Clinical Discovery and Development讀者反饋學(xué)科排名
作者: Lignans 時(shí)間: 2025-3-21 22:32 作者: neolith 時(shí)間: 2025-3-22 02:13 作者: 欲望小妹 時(shí)間: 2025-3-22 05:53 作者: STING 時(shí)間: 2025-3-22 11:18 作者: humectant 時(shí)間: 2025-3-22 15:37 作者: humectant 時(shí)間: 2025-3-22 17:15 作者: Mediocre 時(shí)間: 2025-3-23 01:05
https://doi.org/10.1007/978-3-476-04233-0lized treatment has became the focus of the modern medicine. The various forms of diseases require new diagnostic, therapeutic and prognostic markers that can serve as targets for personalized drug development. Biobank establishment has a great importance globally, as biobank has been identified as 作者: 取之不竭 時(shí)間: 2025-3-23 02:04
Der Schatten des Todes in der Dichtung,ion, format and content find use in basic research, drug and biomarker discovery, as well as for the characterization of proteins. In this chapter, we discuss advantages and limitations of protein microarrays, their features and recent applications. We also consider the different methods to build pr作者: Ancestor 時(shí)間: 2025-3-23 07:28 作者: 藐視 時(shí)間: 2025-3-23 09:49
,Der Mann in Sch?nherrs ?Weibsteufel“,nd post-translational modification on histones, which consist chromatin, have been proved to mediate the epigenetic regulations. Then, DNA methyltransferases and histone deacetylases have been implicated in carcinogenesis to be attractive drug targets..More recently, the filed of epigenome is rapidl作者: 套索 時(shí)間: 2025-3-23 15:19
Dichtung und Welt im Mittelalternucleotide polymorphisms, gene duplications, epigenetics and gene expression. Extensive interindividual differences in drug response and toxicity are observed in most disease areas and pharmacogenomics is one of the factors leading to this variability. In drug development, understanding the pharmaco作者: 得意人 時(shí)間: 2025-3-23 19:08
Endoskopie, Biopsie und Zytologieopments recommendations and outlines for standardization in biobanking processes in clinical studies..The biobank processes are important for the use of samples in developing assays. These measurements are very important in order to document states of health and disease. The data generation and diag作者: Maximize 時(shí)間: 2025-3-23 22:21
Charles Dickens: A Haunting (1960),nsional fashion. Several imaging techniques like X-rays, immunohistochemistry, nuclear magnetic resonance, cryo-electron microscopes, positron emission tomography, green fluorescent protein labelling etc., have been developed and used to understand the structure and function of biological compounds 作者: 大氣層 時(shí)間: 2025-3-24 03:33 作者: 墻壁 時(shí)間: 2025-3-24 10:13
Genomics and Proteomics for Clinical Discovery and Development978-94-017-9202-8Series ISSN 2213-2775 Series E-ISSN 2213-2783 作者: 脫水 時(shí)間: 2025-3-24 13:58 作者: MUMP 時(shí)間: 2025-3-24 16:23
Diastolic Relaxation of the Heartpping about three billion base pair long genetic codes. As an additional outcome, today, we know that the human chromosomes hold about 20,300 genes coding for all functional proteins in the wide versatility of biological activities of cells.作者: Odyssey 時(shí)間: 2025-3-24 21:05 作者: OMIT 時(shí)間: 2025-3-25 01:49 作者: Allowance 時(shí)間: 2025-3-25 06:26
Identification of Missing Proteins: Toward the Completion of Human Proteome,pping about three billion base pair long genetic codes. As an additional outcome, today, we know that the human chromosomes hold about 20,300 genes coding for all functional proteins in the wide versatility of biological activities of cells.作者: eustachian-tube 時(shí)間: 2025-3-25 08:12
Post-translational Modifications in the Human Proteome,rization of post-translation modifications, splice variants, and variants caused by single nucleotide polymorphisms (SNPs) will be necessary to fully understand the role of proteins in human biology and disease.作者: LUT 時(shí)間: 2025-3-25 15:04
Protein Microarrays: Overview, Applications and Challenges,of self-assembled protein microarrays: PISA (protein array to protein Array); DAPA (DNA to Protein Array); PuCa (. puromycin array) and NAPPA (Nucleic Acids Programmable Protein Arrays) and the recent applications of this latter . protein array.作者: FLEET 時(shí)間: 2025-3-25 17:03 作者: Kidney-Failure 時(shí)間: 2025-3-25 20:40
https://doi.org/10.1007/978-3-476-04233-0nt of a quantitative MRM assay is reported for the quantification of putative cardiovascular disease markers. The assay was utilized for the analysis of patient samples taken from the LUNDHEARTGENE biobank.作者: Harridan 時(shí)間: 2025-3-26 03:24 作者: 截?cái)?nbsp; 時(shí)間: 2025-3-26 05:51
https://doi.org/10.1007/978-1-4615-6832-2ce..The Chromosome initiative of the Human Proteome Project currently annotates the number of proteins that are coded by the genome. This chapter gives an introduction to Genomics and Proteomics for Clinical Discovery and Development.作者: fluoroscopy 時(shí)間: 2025-3-26 12:21
https://doi.org/10.1007/978-3-7091-9922-0 will surely enhance our capacity to annotate those gene products and proteoforms that still lack of experimental evidences In this chapter a bioinformatics pipeline to integrate RNA-Seq data, shotgun proteomics experiments and tissue specific gene expression patterns is proposed.作者: 相同 時(shí)間: 2025-3-26 13:15
Introduction to Genomics and Proteomics for Clinical Discovery and Development,ce..The Chromosome initiative of the Human Proteome Project currently annotates the number of proteins that are coded by the genome. This chapter gives an introduction to Genomics and Proteomics for Clinical Discovery and Development.作者: Carminative 時(shí)間: 2025-3-26 17:15 作者: Postulate 時(shí)間: 2025-3-26 22:22 作者: 起波瀾 時(shí)間: 2025-3-27 04:27 作者: APEX 時(shí)間: 2025-3-27 07:44
Identification of Missing Proteins: Toward the Completion of Human Proteome, in size of collaborative efforts (International Human Genome Sequencing Consortium 2004). The social benefit of the knowledge generated is better understanding the expressions of genes in healthy and diseased conditions, which in turn can lead to better diagnosis and treatment of many diseases, inc作者: 搖曳的微光 時(shí)間: 2025-3-27 12:43 作者: hypotension 時(shí)間: 2025-3-27 16:01
Standards for Proteomics Data Dissemination and Experiments Reporting,rieve all the information embedded in the result files, it is important to translate raw files into accepted standards (MIAPE (Minimum Information About a Proteomics Experiment) guidelines and HUPO-PSI xml formats). Data standardization enables to normalize the data obtained from distinct experiment作者: HEAVY 時(shí)間: 2025-3-27 19:38
Mass Spectrometry-Based Protein Sequencing Platforms,, which was improved by Pehr Edman (1949) in 1949. Until mid 1980s, the “Edman degradation” procedure had been used to determine the sequence of the N-terminal 30–40 amino acid residues in a protein routinely. The term “proteome”, linguistically equivalent to the concept of genome, was coined in 199作者: Intersect 時(shí)間: 2025-3-27 23:07
Post-translational Modifications in the Human Proteome,20, 300 human genes. In addition, protein post-translational modifications will be characterized, with the initial goal of detecting phosphorylation, acetylation, and glycosylation sites in each protein. In this chapter, we provide an overview of known post-translational modifications, their known b作者: fiscal 時(shí)間: 2025-3-28 04:03
Biomarker Discovery Utilizing Biobanking Archives and the Diagnostic Market,lized treatment has became the focus of the modern medicine. The various forms of diseases require new diagnostic, therapeutic and prognostic markers that can serve as targets for personalized drug development. Biobank establishment has a great importance globally, as biobank has been identified as 作者: 單色 時(shí)間: 2025-3-28 06:43 作者: VOK 時(shí)間: 2025-3-28 14:12
Clinical Bioinformatics: A New Emerging Science of Biomarker Development,al than patients with more advanced cancer. More than 90 % 5-year survival rate was found to associated with the detection of cancers at the stage one (Etzioni et al. 2003), which need cancer-specific and sensitive biomarkers to diagnose and monitor timely therapeutic interventions (Ullah and Aatif 作者: Decibel 時(shí)間: 2025-3-28 14:37
Rapid Advances in the Field of Epigenetics,nd post-translational modification on histones, which consist chromatin, have been proved to mediate the epigenetic regulations. Then, DNA methyltransferases and histone deacetylases have been implicated in carcinogenesis to be attractive drug targets..More recently, the filed of epigenome is rapidl作者: 哪有黃油 時(shí)間: 2025-3-28 19:18
Pharmacogenomics in Drug Development,nucleotide polymorphisms, gene duplications, epigenetics and gene expression. Extensive interindividual differences in drug response and toxicity are observed in most disease areas and pharmacogenomics is one of the factors leading to this variability. In drug development, understanding the pharmaco作者: 緯線 時(shí)間: 2025-3-28 23:19 作者: 故意 時(shí)間: 2025-3-29 05:19 作者: 免費(fèi) 時(shí)間: 2025-3-29 07:57
Book 2014ho need a good understanding of genomics and proteomics within the clinical field. The book will also be targeted at a broad public as well as readers not specialized within this field..Dr. Marko-Varga is the head of the Head of Div. Clinical Protein Science & Imaging at the Biomedical Center, Dept.作者: irritation 時(shí)間: 2025-3-29 12:45
Genomics and Proteomics for Clinical Discovery and Development作者: 容易懂得 時(shí)間: 2025-3-29 16:51
2213-2775 t a broad public as well as readers not specialized within this field..Dr. Marko-Varga is the head of the Head of Div. Clinical Protein Science & Imaging at the Biomedical Center, Dept.978-94-024-0743-3978-94-017-9202-8Series ISSN 2213-2775 Series E-ISSN 2213-2783 作者: FANG 時(shí)間: 2025-3-29 20:21 作者: 600 時(shí)間: 2025-3-30 01:51 作者: 令人苦惱 時(shí)間: 2025-3-30 06:29
Funktion und Gehalt von Kunst und Dichtung,dditional therapy and detecting recurrence (Fig. 9.1) (Ludwig and Weinstein 2005). Predictive biomarkers allow clinicians to assess clinical effects of chemotherapy and molecular targeted agents on response rate and survival time (Saijo 2012). The patients with poor responses have severe toxicities 作者: 王得到 時(shí)間: 2025-3-30 09:13
,Der Mann in Sch?nherrs ?Weibsteufel“,e, the epigenetic regulators including DNA, histones and RNA, and some epigenetic phenomena such as reprograming and differentiation. Section 10.2 describes epigenome drug targets and current situation of the drug development. In addition, as the latest approaches, we illustrate genomic next generat作者: BRIDE 時(shí)間: 2025-3-30 14:20
